Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 4.0 | 4.0 |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 1.72 | 2.2 |
NAV | ₹110.15 | ₹102.34 |
Fund Started | 16 Nov 2009 | 25 Mar 1997 |
Fund Size | ₹13674.92 Cr | ₹1072.74 Cr |
Exit Load | Exit load for units in excess of 10% of the investment,1% will be charged for redemption within 1 year. | Exit load of 1%, if redeemed within 30 days. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 29.30% | 28.35% |
3 Year | 24.85% | 26.27% |
5 Year | 24.99% | 25.03% |
1 Year
3 Year
5 Year
Equity | 99.33% | 99.31% |
Cash | 0.67% | 0.69% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
ICICI Bank Ltd. | 4.17% |
Multi Commodity Exchange Of India Ltd. | 3.61% |
HDFC Bank Ltd. | 3.53% |
NTPC Ltd. | 3.46% |
KEC International Ltd. | 3.00% |
Tech Mahindra Ltd. | 2.86% |
The Federal Bank Ltd. | 2.48% |
Reliance Industries Ltd. | 2.38% |
Karur Vysya Bank Ltd. | 2.28% |
State Bank of India | 2.26% |
Name | Assets |
---|---|
HDFC Bank Ltd. | 7.21% |
Infosys Ltd. | 4.57% |
ICICI Bank Ltd. | 4.12% |
Dr. Reddy's Laboratories Ltd. | 3.14% |
State Bank of India | 2.74% |
NTPC Ltd. | 2.64% |
REC Ltd. | 2.49% |
Tech Mahindra Ltd. | 2.23% |
Amber Enterprises India Ltd. | 2.16% |
Suven Pharmaceuticals Ltd. | 2.07% |
Name | Sonal Gupta | Satish Ramanathan |
Start Date | 01 Apr 2024 | 01 Oct 2024 |
Name
Start Date
Description | The Scheme seeks to generate long term capital appreciation from a diversified portfolio of predominantly equity and equity related securities, in the Indian markets with higher focus on undervalued securities. It could also additionally invest in Foreign Securities in international markets. | The scheme aims to provide long term capital growth by investing primarily in a well-diversified portfolio of undervalued securities. |
Launch Date | 16 Nov 2009 | 25 Mar 1997 |
Description
Launch Date